- Founded
- 2015
- Employees
- 51-100
- Total Funding
- $325M
Founded by Michael Gilman, Steve Shamah, Tariq Kassum in 2015.
About Obsidian Therapeutics
Obsidian Therapeutics is pioneering engineered cell and gene therapies to deliver transformative outcomes for patients. Obsidian’s programs apply our cytoDRiVE® technology in Cell and Gene therapy products to control expression of proteins for enhanced therapeutic efficacy and safety. Obsidian’s lead program is currently in clinical development for the treatment of patients with metastatic melanoma and non-small cell lung cancer. We’re proud of our diverse talented team and committed to cultivating an environment of inclusion where each person feels a strong sense of belonging and is supported to continuously learn and contribute their best work.
Leadership at Obsidian Therapeutics
The team at the top of the org chart.
Madan Jagasia
Chief Executive Officer
65 reports
Parameswaran Hari
Chief Development Officer
28 reports
Jennifer Peterson
Chief People Officer
4 reports
Nic Betts
Senior Vice President, Digital & Facilities
2 reports
Jeffrey Trigilio
Chief Financial And Operating Officer
10 reports
Giri Ramsingh
Vice President Clinical Sciences
4 reports
Dana Alexander
Chief Technical Officer
11 reports
Board
Maria Fardis
Executive Chair
Peter Barrett
Director
Cariad Chester
Director
Jason Gardner
Director
Heidi Hagen
Director
Rob Ross
Director
Open Jobs at Obsidian Therapeutics (7)
- Obsidian Therapeutics · Bedford, MA (HYBRID) · 1d$198k
- Obsidian Therapeutics · Bedford, MA (HYBRID) · 2d$81k
- Obsidian Therapeutics · Bedford, MA · 8d$131k
- Obsidian Therapeutics · Remote · 14d$221k
- Obsidian Therapeutics · Cambridge, MA (HYBRID) · 18d$176k
- Obsidian Therapeutics · Bedford, MA (HYBRID) · 18d$219k
- Obsidian Therapeutics · Cambridge, MA · 18d
Similar companies hiring
Top employers in Health Care